Company · CIK 0000882796 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
BIOCRYST PHARMACEUTICALS INC · BCRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2017 MForm 4 → | Mar 22, 10:40 am EDT | Thomas R Staab IISenior Vice President and CFO | 3,250 | $3.78 | $12,285 | 144,710 | — | plan? |
| Mar 16, 2017 FMForm 4 → | Mar 20, 3:01 pm EDT | Thomas R Staab IISenior Vice President and CFO | 48,763 | $4.44 | $216,610 | 141,460 | — | plan? |
| Mar 10, 2017 SForm 4 → | Mar 14, 1:47 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,250 | $9.06 | $29,445 | 117,313 | −2.70% | plan? |
| Mar 10, 2017 MForm 4 → | Mar 14, 1:47 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,250 | $3.78 | $12,285 | 120,563 | — | plan? |
| Mar 8, 2017 SForm 4 → | Mar 10, 4:19 pm EST | Thomas R Staab IISenior Vice President and CFO | 6,500 | $8.43 | $54,763 | 117,313 | −5.25% | plan? |
| Mar 8, 2017 MForm 4 → | Mar 10, 4:19 pm EST | Thomas R Staab IISenior Vice President and CFO | 6,500 | $3.78 | $24,570 | 123,813 | — | plan? |
| Mar 6, 2017 SForm 4 → | Mar 8, 8:05 am EST | Thomas R Staab IISenior Vice President and CFO | 3,250 | $7.90 | $25,675 | 117,313 | −2.70% | plan? |
| Mar 6, 2017 MForm 4 → | Mar 8, 8:05 am EST | Thomas R Staab IISenior Vice President and CFO | 3,250 | $3.78 | $12,285 | 120,563 | — | plan? |
| Mar 2, 2017 AForm 4 → | Mar 2, 3:07 pm EST | Robert Alexander IngramDirector | 1,602 | $6.24 | $9,996 | 5,823 | — | plan? |
| Mar 1, 2017 AForm 4 → | Mar 2, 3:05 pm EST | Nancy J HutsonDirector | 1,602 | $6.24 | $9,996 | 30,266 | — | plan? |
| Mar 1, 2017 AForm 4 → | Mar 2, 3:03 pm EST | Fred E CohenDirector | 1,602 | $6.24 | $9,996 | 117,469 | — | plan? |
| Jan 20, 2017 FForm 4 → | Jan 24, 9:28 am EST | Alane P BarnesVP, General Counsel & Corp Sec | 2,599 | $5.95 | $15,464 | 75,497 | — | plan? |
| Jan 20, 2017 FForm 4 → | Jan 24, 9:25 am EST | Yarlagadda S BabuSenior VP - Drug Discovery | 5,083 | $5.95 | $30,244 | 104,706 | — | plan? |
| Jan 20, 2017 FForm 4 → | Jan 24, 9:22 am EST | William P SheridanSenior VP - CMO | 5,761 | $5.95 | $34,278 | 82,916 | — | plan? |
| Jan 20, 2017 FForm 4 → | Jan 24, 9:20 am EST | Thomas R Staab IISenior Vice President and CFO | 5,198 | $5.95 | $30,928 | 117,313 | — | plan? |
| Jan 20, 2017 FForm 4 → | Jan 24, 9:17 am EST | Jon P StonehousePresident & CEO, Director | 10,572 | $5.95 | $62,903 | 645,418 | — | plan? |
| Jan 1, 2017 FForm 4 → | Jan 3, 2:13 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 1,281 | $6.33 | $8,109 | 78,096 | — | plan? |
| Jan 1, 2017 FForm 4 → | Jan 3, 2:09 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 1,639 | $6.33 | $10,375 | 109,789 | — | plan? |
| Jan 1, 2017 FForm 4 → | Jan 3, 2:06 pm EST | William P SheridanSenior VP - CMO | 2,081 | $6.33 | $13,173 | 88,677 | — | plan? |
| Jan 1, 2017 FForm 4 → | Jan 3, 2:03 pm EST | Thomas R Staab IISenior Vice President and CFO | 1,676 | $6.33 | $10,609 | 122,511 | — | plan? |
| Jan 1, 2017 FForm 4 → | Jan 3, 1:59 pm EST | Jon P StonehousePresident & CEO, Director | 8,595 | $6.33 | $54,406 | 655,990 | — | plan? |
| Dec 19, 2016 SForm 4 → | Dec 21, 10:42 am EST | Thomas R Staab IISenior Vice President and CFO | 3,250 | $7.45 | $24,213 | 124,187 | −2.55% | plan? |
| Dec 19, 2016 MForm 4 → | Dec 21, 10:42 am EST | Thomas R Staab IISenior Vice President and CFO | 3,250 | $3.78 | $12,285 | 127,437 | — | plan? |
| Dec 1, 2016 AForm 4 → | Dec 2, 2:09 pm EST | Robert Alexander IngramDirector | 1,788 | $5.59 | $9,995 | 4,221 | — | plan? |
| Dec 1, 2016 AForm 4 → | Dec 2, 2:06 pm EST | Nancy J HutsonDirector | 1,788 | $5.59 | $9,995 | 28,664 | — | plan? |
| Dec 1, 2016 AForm 4 → | Dec 2, 2:03 pm EST | Fred E CohenDirector | 1,788 | $5.59 | $9,995 | 115,867 | — | plan? |
| Sep 14, 2016 SForm 4 → | Sep 16, 10:54 am EDT | Alane P BarnesVP, General Counsel & Corp Sec | 8,357 | $4.27 | $35,684 | 79,377 | −9.53% | plan? |
| Sep 1, 2016 AForm 4 → | Sep 6, 3:27 pm EDT | Robert Alexander IngramDirector | 2,433 | $4.11 | $10,000 | 2,433 | — | plan? |
| Sep 1, 2016 AForm 4 → | Sep 6, 3:25 pm EDT | Nancy J HutsonDirector | 2,433 | $4.11 | $10,000 | 26,876 | — | plan? |
| Sep 1, 2016 AForm 4 → | Sep 6, 3:24 pm EDT | Fred E CohenDirector | 2,433 | $4.11 | $10,000 | 114,079 | — | plan? |
| Aug 25, 2016 SForm 4 → | Aug 29, 10:46 am EDT | Yarlagadda S BabuSenior VP - Drug Discovery | 30,000 | $4.06 | $121,800 | 111,428 | −21.2% | plan? |
| Aug 12, 2016 SForm 4 → | Aug 16, 6:11 pm EDT | BAKER BROS. ADVISORS LP +310% Owner | 4,046,590 | $5.00 | $20,251,103 | 9,418,390 | −30.1% | plan? |
| Aug 11, 2016 SForm 4 → | Aug 15, 2:07 pm EDT | Thomas R Staab IISenior Vice President and CFO | 5,864 | $5.18 | $30,388 | 124,187 | −4.51% | plan? |
| Aug 9, 2016 SForm 4 → | Aug 11, 1:53 pm EDT | Thomas R Staab IISenior Vice President and CFO | 14,577 | $4.43 | $64,576 | 130,051 | −10.1% | plan? |
| May 31, 2016 AForm 4 → | Jun 2, 9:45 am EDT | Nancy J HutsonDirector | 2,581 | $3.39 | $8,750 | 24,443 | — | plan? |
| May 31, 2016 AForm 4 → | Jun 2, 9:42 am EDT | Fred E CohenDirector | 2,581 | $3.39 | $8,750 | 111,646 | — | plan? |
| Mar 1, 2016 FForm 4 → | Mar 3, 9:56 am EST | Alane P BarnesVP, General Counsel & Corp Sec | 687 | $2.13 | $1,463 | 85,416 | — | plan? |
| Mar 1, 2016 FForm 4 → | Mar 3, 9:47 am EST | Yarlagadda S BabuSenior VP - Drug Discovery | 906 | $2.13 | $1,930 | 141,428 | — | plan? |
| Mar 1, 2016 FForm 4 → | Mar 3, 9:45 am EST | William P SheridanSenior VP - CMO | 799 | $2.13 | $1,702 | 90,052 | — | plan? |
| Mar 1, 2016 FForm 4 → | Mar 3, 9:43 am EST | Thomas R Staab IISenior Vice President and CFO | 465 | $2.13 | $990 | 144,628 | — | plan? |
| Mar 1, 2016 FForm 4 → | Mar 3, 9:41 am EST | Jon P StonehousePresident & CEO, Director | 2,761 | $2.13 | $5,881 | 664,585 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 1, 4:08 pm EST | Charles A SandersDirector | 4,396 | $1.99 | $8,748 | 12,971 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 1, 4:05 pm EST | Nancy J HutsonDirector | 4,396 | $1.99 | $8,748 | 21,862 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 1, 4:03 pm EST | Fred E CohenDirector | 4,396 | $1.99 | $8,748 | 109,065 | — | plan? |
| Feb 5, 2016 PForm 4 → | Feb 9, 5:24 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 45,000 | $6.33 | $284,657 | 12,894,240 | +0.35% | plan? |
| Feb 2, 2016 PForm 4 → | Feb 4, 5:15 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 207,715 | $6.43 | $1,336,586 | 12,849,240 | +1.64% | plan? |
| Jan 29, 2016 MForm 4 → | Feb 1, 2:34 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 19,368 | $1.42 | $27,503 | 85,057 | — | plan? |
| Jan 27, 2016 PForm 4 → | Jan 29, 4:42 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 88,345 | $6.95 | $613,986 | 12,641,525 | +0.70% | plan? |
| Jan 26, 2016 FForm 4 → | Jan 27, 1:41 pm EST | Lynne PowellSenior VP - CCO | 3,850 | $7.29 | $28,067 | 8,605 | — | plan? |
| Jan 21, 2016 PForm 4 → | Jan 25, 6:10 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 106,800 | $7.28 | $777,757 | 12,553,180 | +0.86% | plan? |
| Jan 20, 2016 FForm 4 → | Jan 22, 9:27 am EST | Alane P BarnesVP, General Counsel & Corp Sec | 2,599 | $7.55 | $19,622 | 65,689 | — | plan? |
| Jan 20, 2016 FForm 4 → | Jan 22, 9:24 am EST | Yarlagadda S BabuSenior VP - Drug Discovery | 4,724 | $7.55 | $35,666 | 142,334 | — | plan? |
| Jan 20, 2016 FForm 4 → | Jan 22, 9:21 am EST | William P SheridanSenior VP - CMO | 5,359 | $7.55 | $40,460 | 88,967 | — | plan? |
| Jan 20, 2016 FForm 4 → | Jan 22, 9:18 am EST | Thomas R Staab IISenior Vice President and CFO | 4,823 | $7.55 | $36,414 | 145,093 | — | plan? |
| Jan 20, 2016 FForm 4 → | Jan 22, 9:16 am EST | Jon P StonehousePresident & CEO, Director | 10,624 | $7.55 | $80,211 | 665,702 | — | plan? |
| Jan 20, 2016 MForm 4 → | Jan 21, 1:12 pm EST | Jon P StonehousePresident & CEO, Director | 24,096 | $4.15 | $99,998 | 676,326 | — | plan? |
| Jan 19, 2016 MForm 4 → | Jan 21, 11:04 am EST | Thomas R Staab IISenior Vice President and CFO | 15,000 | $1.81 | $27,200 | 149,916 | — | plan? |
| Jan 15, 2016 PForm 4 → | Jan 20, 7:13 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 344,895 | $7.28 | $2,510,143 | 12,446,380 | +2.85% | plan? |
| Jan 1, 2016 FForm 4 → | Jan 5, 1:31 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 1,281 | $10.32 | $13,220 | 68,288 | — | plan? |
| Jan 1, 2016 FForm 4 → | Jan 5, 1:29 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 1,639 | $10.32 | $16,914 | 147,058 | — | plan? |
| Jan 1, 2016 FForm 4 → | Jan 5, 1:27 pm EST | William P SheridanSenior VP - CMO | 2,081 | $10.32 | $21,476 | 94,326 | — | plan? |
| Jan 1, 2016 FForm 4 → | Jan 5, 1:25 pm EST | Thomas R Staab IISenior Vice President and CFO | 1,676 | $10.32 | $17,296 | 134,916 | — | plan? |
| Jan 1, 2016 FForm 4 → | Jan 5, 1:23 pm EST | Jon P StonehousePresident & CEO, Director | 8,091 | $10.32 | $83,499 | 652,230 | — | plan? |
| Dec 21, 2015 SForm 4 → | Dec 22, 3:45 pm EST | Thomas R Staab IISenior Vice President and CFO | 3,052 | $10.86 | $33,145 | 136,592 | −2.19% | plan? |
| Dec 17, 2015 SForm 4 → | Dec 18, 2:54 pm EST | Thomas R Staab IISenior Vice President and CFO | 3,000 | $10.49 | $31,470 | 139,644 | −2.10% | plan? |
| Nov 30, 2015 AForm 4 → | Dec 3, 4:22 pm EST | Charles A SandersDirector | 824 | $10.61 | $8,743 | 8,575 | — | plan? late |
| Nov 30, 2015 AForm 4 → | Dec 3, 4:20 pm EST | Nancy J HutsonDirector | 824 | $10.61 | $8,743 | 17,466 | — | plan? late |
| Nov 30, 2015 AForm 4 → | Dec 3, 4:19 pm EST | Fred E CohenDirector | 824 | $10.61 | $8,743 | 104,669 | — | plan? late |
| Aug 31, 2015 AForm 4 → | Sep 2, 2:27 pm EDT | Charles A SandersDirector | 751 | $11.64 | $8,742 | 7,751 | — | plan? |
| Aug 31, 2015 AForm 4 → | Sep 2, 2:24 pm EDT | Nancy J HutsonDirector | 751 | $11.64 | $8,742 | 16,642 | — | plan? |
| Aug 31, 2015 AForm 4 → | Sep 2, 2:22 pm EDT | Fred E CohenDirector | 751 | $11.64 | $8,742 | 103,845 | — | plan? |
| Jul 20, 2015 SForm 4 → | Jul 22, 5:21 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,500 | $16.50 | $57,750 | 142,644 | −2.39% | plan? |
| Jul 15, 2015 FMForm 4 → | Jul 17, 9:45 am EDT | Jon P StonehousePresident & CEO, Director | 59,394 | $13.47 | $799,974 | 659,211 | — | plan? |
| Jun 22, 2015 SForm 4 → | Jun 24, 4:57 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,750 | $16.00 | $60,000 | 146,144 | −2.50% | plan? |
| Jun 22, 2015 MForm 4 → | Jun 24, 4:57 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,750 | $4.73 | $17,738 | 149,894 | — | plan? |
| Jun 19, 2015 SForm 4 → | Jun 22, 4:51 pm EDT | Alane P BarnesVP, General Counsel & Corp Sec | 3,000 | $15.00 | $45,000 | 68,876 | −4.17% | plan? |
| Jun 19, 2015 SForm 4 → | Jun 22, 4:48 pm EDT | William P SheridanSenior VP - CMO | 70,389 | $15.05 | $1,059,354 | 95,123 | −42.5% | plan? |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:48 pm EDT | William P SheridanSenior VP - CMO | 70,389 | $1.20 | $84,467 | 165,512 | — | plan? |
| Jun 19, 2015 SForm 4 → | Jun 22, 4:34 pm EDT | Jon P StonehousePresident & CEO, Director | 20,000 | $15.02 | $300,400 | 650,869 | −2.98% | plan? |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:34 pm EDT | Jon P StonehousePresident & CEO, Director | 20,000 | $1.20 | $24,000 | 670,869 | — | plan? |
| Jun 18, 2015 MForm 4 → | Jun 22, 4:38 pm EDT | Thomas R Staab IISenior Vice President and CFO | 9,375 | $3.78 | $35,438 | 149,319 | — | plan? |
| Jun 18, 2015 SForm 4 → | Jun 22, 4:38 pm EDT | Thomas R Staab IISenior Vice President and CFO | 16,375 | $14.36 | $235,150 | 146,144 | −10.1% | plan? |
| Jun 5, 2015 SForm 4 → | Jun 9, 1:33 pm EDT | Thomas R Staab IISenior Vice President and CFO | 6,000 | $12.75 | $76,500 | 153,144 | −3.77% | plan? |
| Jun 1, 2015 SForm 4 → | Jun 2, 2:57 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,000 | $12.00 | $36,000 | 159,144 | −1.85% | plan? |
| May 29, 2015 AForm 4 → | Jun 1, 3:53 pm EDT | Fred E CohenDirector | 780 | $11.21 | $8,744 | 103,094 | — | plan? |
| May 18, 2015 SForm 4 → | May 19, 4:53 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,000 | $11.00 | $33,000 | 162,144 | −1.82% | plan? |
| Mar 19, 2015 SForm 4 → | Mar 20, 4:30 pm EDT | Yarlagadda S BabuSenior VP - Drug Discovery | 12,105 | $10.16 | $122,987 | 148,697 | −7.53% | plan? |
| Mar 5, 2015 SForm 4 → | Mar 6, 2:14 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 37,400 | $10.59 | $396,066 | 160,802 | −18.9% | plan? |
| Mar 4, 2015 SForm 4 → | Mar 5, 2:58 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 10,495 | $10.50 | $110,198 | 198,202 | −5.03% | plan? |
| Mar 1, 2015 FForm 4 → | Mar 3, 3:59 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 1,120 | $10.20 | $11,424 | 71,876 | — | plan? |
| Mar 1, 2015 FForm 4 → | Mar 3, 3:56 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 1,634 | $10.20 | $16,667 | 208,697 | — | plan? |
| Mar 1, 2015 FForm 4 → | Mar 3, 3:54 pm EST | William P SheridanSenior VP - CMO | 1,739 | $10.20 | $17,738 | 95,123 | — | plan? |
| Mar 1, 2015 FForm 4 → | Mar 3, 3:51 pm EST | Thomas R Staab IISenior Vice President and CFO | 465 | $10.20 | $4,743 | 165,144 | — | plan? |
| Mar 1, 2015 FForm 4 → | Mar 3, 3:48 pm EST | Jon P StonehousePresident & CEO, Director | 5,118 | $10.20 | $52,204 | 650,869 | — | plan? |
| Feb 27, 2015 AForm 4 → | Mar 3, 3:45 pm EST | Fred E CohenDirector | 857 | $10.20 | $8,741 | 102,314 | — | plan? |
| Feb 20, 2015 PForm 4 → | Feb 23, 12:50 pm EST | Nancy J HutsonDirector | 10,000 | $10.27 | $102,700 | 15,891 | +170% | plan? |
| Jan 26, 2015 AForm 4 → | Jan 28, 3:10 pm EST | Lynne PowellSenior VP - CCO | 10,000 | — | — | 10,000 | — | plan? |
| Jan 20, 2015 FForm 4 → | Jan 22, 12:18 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 2,210 | $11.17 | $24,686 | 72,370 | — | plan? |
| Jan 20, 2015 FForm 4 → | Jan 22, 12:16 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 4,362 | $11.17 | $48,724 | 210,331 | — | plan? |
| Jan 20, 2015 FForm 4 → | Jan 22, 12:14 pm EST | William P SheridanSenior VP - CMO | 5,074 | $11.17 | $56,677 | 95,609 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2016 MForm 4 → | Jan 21, 11:04 am EST | Thomas R Staab IISenior Vice President and CFO | 15,000 | — | — | 87,500 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:18 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 43,997 | — | — | 43,997 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:16 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 62,573 | — | — | 62,573 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:13 pm EST | Lynne PowellSenior VP - CCO | 62,573 | — | — | 62,573 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:11 pm EST | William P SheridanSenior VP - CMO | 71,698 | — | — | 71,698 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:09 pm EST | Thomas R Staab IISenior Vice President and CFO | 62,573 | — | — | 62,573 | — | |
| Dec 29, 2015 AForm 4 → | Dec 31, 2:07 pm EST | Jon P StonehousePresident & CEO, Director | 162,950 | — | — | 162,950 | — | |
| Sep 25, 2015 AForm 4 → | Sep 29, 3:01 pm EDT | Sanj K PatelDirector | 16,667 | — | — | 16,667 | — | |
| Aug 5, 2015 AForm 4 → | Aug 7, 5:13 pm EDT | Robert Alexander IngramDirector | 18,750 | — | — | 18,750 | — | |
| Jul 15, 2015 MForm 4 → | Jul 17, 9:45 am EDT | Jon P StonehousePresident & CEO, Director | 33,868 | — | — | 416,132 | — | |
| Jun 22, 2015 MForm 4 → | Jun 24, 4:57 pm EDT | Thomas R Staab IISenior Vice President and CFO | 3,750 | — | — | 11,750 | — | |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:48 pm EDT | William P SheridanSenior VP - CMO | 70,389 | — | — | 42,112 | — | |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:34 pm EDT | Jon P StonehousePresident & CEO, Director | 20,000 | — | — | 80,000 | — | |
| Jun 18, 2015 MForm 4 → | Jun 22, 4:38 pm EDT | Thomas R Staab IISenior Vice President and CFO | 9,375 | — | — | 101,760 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:57 pm EDT | Charles A SandersDirector | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:55 pm EDT | Kenneth B Lee Jr.Director | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:53 pm EDT | Nancy J HutsonDirector | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:51 pm EDT | Stanley C ErckDirector | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:49 pm EDT | Fred E CohenDirector | 15,000 | — | — | 15,000 | — | |
| May 20, 2015 AForm 4 → | May 22, 2:46 pm EDT | George B AbercrombieDirector | 15,000 | — | — | 15,000 | — | |
| May 13, 2015 AForm 4 → | Jun 16, 3:32 pm EDT | Alane P BarnesVP, General Counsel & Corp Sec | 17,000 | — | — | 17,000 | — | late |
| May 13, 2015 AForm 4 → | Jun 16, 3:29 pm EDT | Yarlagadda S BabuSenior VP - Drug Discovery | 17,000 | — | — | 17,000 | — | late |
| May 13, 2015 AForm 4 → | Jun 16, 3:27 pm EDT | William P SheridanSenior VP - CMO | 17,000 | — | — | 17,000 | — | late |
| May 13, 2015 AForm 4 → | Jun 16, 3:24 pm EDT | Thomas R Staab IISenior Vice President and CFO | 17,000 | — | — | 17,000 | — | late |
| May 13, 2015 AForm 4 → | Jun 16, 3:22 pm EDT | Jon P StonehousePresident & CEO, Director | 25,000 | — | — | 25,000 | — | late |
| Jan 26, 2015 AForm 4 → | Jan 28, 3:10 pm EST | Lynne PowellSenior VP - CCO | 190,000 | — | — | 190,000 | — | |
| Jan 8, 2015 MForm 4 → | Jan 9, 1:19 pm EST | Fred E CohenDirector | 100,000 | — | — | 0 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:12 pm EST | Alane P BarnesVP, General Counsel & Corp Sec | 23,200 | — | — | 23,200 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:10 pm EST | Yarlagadda S BabuSenior VP - Drug Discovery | 42,400 | — | — | 42,400 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:07 pm EST | William P SheridanSenior VP - CMO | 52,000 | — | — | 52,000 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 4:05 pm EST | Thomas R Staab IISenior Vice President and CFO | 42,400 | — | — | 42,400 | — |